Andrew J. Farrall

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

Annamaria Colao, Marcello D. Bronstein, Pamela U. Freda et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 389 citations · Full text

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR^® (long‐acting repeatable octreotide) in the primary therapy of patients with acromegaly

Moisés Mercado, Fátima Borges, Hakim Bouterfa et al. · Clinical Endocrinology · 2007 · 209 citations · Full text

Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial

Stephan Petersenn, Jochen Schopohl, Ariel Barkan et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 202 citations

Influence of Intracerebral Hemorrhage Location on Incidence, Characteristics, and Outcome

Neshika Samarasekera, Arthur F. Fonville, Christine Lerpiniere et al. · Stroke · 2015 · 165 citations · Full text

Octreotide LAR <i>vs.</i> surgery in newly diagnosed patients with acromegaly: a randomized, open‐label, multicentre study

Annamaria Colao, Paolo Cappabianca, Philippe Caron et al. · Clinical Endocrinology · 2008 · 114 citations